Bristol-Myers Squibb Company (BMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 5,970,000 | 3,775,000 | 2,462,000 | -8,933,000 | -9,009,000 |
| Depreciation Amortization | 3,034,000 | 2,023,000 | 1,012,000 | 9,600,000 | 7,720,000 |
| Income taxes - deferred | -573,000 | -214,000 | 223,000 | -2,089,000 | -1,298,000 |
| Accounts receivable | -314,000 | -469,000 | 15,000 | 264,000 | 121,000 |
| Other Working Capital | 1,199,000 | -1,856,000 | -1,871,000 | 810,000 | -466,000 |
| Other Operating Activity | 2,866,000 | 2,612,000 | 113,000 | 15,538,000 | 13,683,000 |
| Operating Cash Flow | $12,182,000 | $5,871,000 | $1,954,000 | $15,190,000 | $10,751,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -349,000 | -513,000 | -416,000 | 353,000 | 662,000 |
| PPE Investments | -941,000 | -621,000 | -260,000 | -1,248,000 | -870,000 |
| Net Acquisitions | -1,445,000 | 150,000 | 165,000 | -20,722,000 | -21,008,000 |
| Sale Of Investment | 61,000 | 12,000 | 12,000 | 265,000 | 60,000 |
| Investing Cash Flow | $-2,674,000 | $-972,000 | $-499,000 | $-21,352,000 | $-21,156,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 431,000 | 426,000 | 368,000 | 3,086,000 | 3,491,000 |
| Debt Issued | 0 | 0 | 0 | 12,883,000 | 12,883,000 |
| Debt Repayment | -872,000 | -643,000 | N/A | -2,873,000 | -2,873,000 |
| Common Stock Issued | -95,000 | -92,000 | -103,000 | N/A | -87,000 |
| Dividend Paid | -3,783,000 | -2,520,000 | -1,258,000 | -4,863,000 | -3,645,000 |
| Other Financing Activity | 0 | 0 | 0 | -3,106,000 | -3,000,000 |
| Financing Cash Flow | $-4,319,000 | $-2,829,000 | $-993,000 | $5,127,000 | $6,769,000 |
| Exchange Rate Effect | 190,000 | 194,000 | 66,000 | -137,000 | 10,000 |
| Beginning Cash Position | 10,347,000 | 10,347,000 | 10,347,000 | 11,519,000 | 11,519,000 |
| End Cash Position | 15,726,000 | 12,611,000 | 10,875,000 | 10,347,000 | 7,893,000 |
| Net Cash Flow | $5,379,000 | $2,264,000 | $528,000 | $-1,172,000 | $-3,626,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 12,182,000 | 5,871,000 | 1,954,000 | 15,190,000 | 10,751,000 |
| Capital Expenditure | -941,000 | -621,000 | -260,000 | -1,248,000 | -870,000 |
| Free Cash Flow | 11,241,000 | 5,250,000 | 1,694,000 | 13,942,000 | 9,881,000 |